Midecamycin (Acetate)

Midecamycin (Acetate) is a macrolide antibiotic with actions and uses similar to those of erythromycin but somewhat less active. It has been given by mouth to treat variety of bacterial infections like respiratory tract, ear, skin infections etc. Antibiotics require constant drug level in body for therapeutic effect. This is achieved by taking the drug at regular interval of time throughout the day and night as prescribed. Midecamycin (Acetate) is important to take the drug for the full time period as prescribed. If you discontinue the drug it may result in ineffective treatment.

Brands
MIOMAX MIOMAX
Adult Dose
Dose: 200 to 400 mg
Single Dose: 300 (300)
Frequency: 8 hourly
Route: PO
Instructions: As Required
Neonatal
Paedriatic
Dose: 6.66 to 13.33 mg/kg
Single Dose: 10 (9.995)
Frequency: 8 hourly
Route: Oral
Instructions: -
Characteristics
. It is of Semi Synthetic origin. It belongs to Antibiotic, Macrolide pharmacological group.The Molecular Weight of Midecamycin (Acetate) is 814.00.
Contraindications
Midecamycin (Acetate) is contraindicated in conditions like Hypersensitivity.
Effects
The symptomatic adverse reactions produced by Midecamycin (Acetate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Vomiting, Anorexia, Diarrhea, Abdominal pain, Urticaria, StomatitisX, Elevation of liver enzymes, Eruptions, Eosinophilia.
Indications
Midecamycin (Acetate) is primarily indicated in conditions like Bronchitis, Laryngopharyngitis, Otitis media, Periodontitis, Pneumonia, Respiratory tract infections, Skin infections, Subcutaneous abscess, Tonsillitis.
Interactions
No data regarding the interactions of Midecamycin (Acetate) was found.
Interfrence
Risks
Drug should not be given to Paediatrics, Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
As a general rule, the duration of treatment should limited to a minimum required for the treatment of disesase, after the susceptibility being confirmed, in order to avoid possible occurrence of resistant bacteria.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.